Niven Mehra
Nijmegen, GE, Netherlands
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 171 publications
Shallow Whole-Genome Sequencing to Assess Genomic Instability and Predict Treatment Response in Metastatic Castration-Resistant Prostate Cancer.
Journal: JCO precision oncology
Published: July 08, 2026
Detection of Homologous Recombination Repair Gene Mutations by Tumor Tissue and Circulating Tumor DNA Testing in Prostate Cancer in the Phase III PROpel Trial.
Journal: JCO precision oncology
Published: May 11, 2026
Lutetium-177-PSMA-617 in Oligo-metastatic Hormone-sensitive Prostate Cancer (BULLSEYE): A Trial Update.
Journal: European urology focus
Published: April 14, 2026
From Genomic Testing to Olaparib Treatment: Real-World Utilization and Outcomes in BRCA-Mutated Metastatic Castration-Resistant Prostate Cancer.
Journal: Drugs - real world outcomes
Published: March 10, 2026
Assessing the Detection Power of Genome-Wide Copy Number Variation Profiles in Prostate Cancer Using Simulated Shallow Whole-Genome Sequencing Data.
Journal: JCO clinical cancer informatics
Published: January 23, 2026
Efficacy of Olaparib Plus Abiraterone for Patients with Metastatic Castration-resistant Prostate Cancer and Single Homologous Recombination Repair Gene Mutations in PROpel.
Journal: European urology oncology
Published: January 22, 2026
Effect of Enzalutamide on Morphine Exposure in Patients with Prostate Cancer.
Journal: Clinical pharmacokinetics
Published: January 15, 2026
Germline CDK12 variants in aggressive prostate cancer.
Journal: Cancer discovery
Published: January 14, 2026
EMETPRO: a multicentric, international, retrospective analysis evaluating patients with metastatic hormone-sensitive prostate cancer with early progression.
Journal: Prostate cancer and prostatic diseases
Published: January 03, 2026
Discrepancies Between Global Consensus and Local Implementation in the Management of Advanced Prostate Cancer.
Journal: European urology open science
Published: December 23, 2025
Advanced and metastatic prostate cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up.
Journal: Annals of oncology : official journal of the European Society for Medical Oncology
Published: November 28, 2025
Longitudinal genome-wide aneuploidy measurements in circulating cell-free DNA to predict lack of benefit from pembrolizumab in patients with metastatic urothelial cancer.
Journal: Molecular oncology
Published: November 10, 2025
Last Updated: 09/26/2026